Page last updated: 2024-10-24

calcitonin gene-related peptide binding

Definition

Target type: molecularfunction

Binding to calcitonin gene-related peptide (CGRP). [GOC:bhm, PMID:10882736]

Calcitonin gene-related peptide (CGRP) binding involves the interaction of CGRP with its cognate receptor, the CGRP receptor (CGRP-R), which is a heterodimer composed of the calcitonin receptor-like receptor (CLR) and the receptor activity modifying protein 1 (RAMP1). The binding of CGRP to CGRP-R triggers a series of intracellular signaling events that ultimately lead to the activation of downstream effectors. The molecular function of CGRP binding can be described in detail as follows:

1. **Ligand Recognition:** CGRP, a 37-amino acid peptide, binds to the extracellular domain of the CLR subunit of the CGRP-R. The binding is highly specific, with CGRP showing a much higher affinity for CGRP-R than for other receptors, such as the calcitonin receptor.

2. **Receptor Activation:** Upon CGRP binding, the CLR subunit undergoes a conformational change, which activates the receptor complex. This activation involves the recruitment of G proteins, specifically Gαs, to the intracellular domain of the CLR subunit.

3. **Signal Transduction:** The activated Gαs protein dissociates from the receptor and activates adenylyl cyclase, an enzyme responsible for converting ATP into cyclic adenosine monophosphate (cAMP). cAMP acts as a second messenger, triggering a cascade of downstream signaling events.

4. **Activation of Downstream Effectors:** Increased cAMP levels activate protein kinase A (PKA), which phosphorylates various intracellular proteins involved in cellular processes, including gene expression, cellular differentiation, and proliferation.

5. **Biological Effects:** CGRP binding and subsequent signal transduction mediate a wide range of biological effects, including:
- Vasodilation: CGRP promotes the relaxation of vascular smooth muscle, leading to vasodilation and increased blood flow.
- Neuroprotection: CGRP has neuroprotective effects, reducing neuronal damage in various neurological conditions.
- Pain Modulation: CGRP plays a role in pain perception and transmission, contributing to both acute and chronic pain.
- Inflammation: CGRP is involved in the inflammatory response, contributing to the recruitment of immune cells to the site of injury.

6. **Therapeutic Implications:** The involvement of CGRP in various physiological and pathological processes has led to the development of CGRP-targeted therapies, such as monoclonal antibodies and small-molecule inhibitors, for the treatment of migraines, cluster headaches, and other conditions associated with CGRP dysregulation.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Receptor activity-modifying protein 1A receptor activity-modifying protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60894]Homo sapiens (human)

Compounds (4)

CompoundDefinitionClassesRoles
telcagepanttelcagepant: structure in first source
mk 3207
mk-8825
atogepantatogepant : A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine.azaspiro compound;
organic heterotetracyclic compound;
piperidones;
secondary carboxamide;
trifluorobenzene
calcitonin gene-related peptide receptor antagonist